Friday, May 26, 2017

DYNEMIC PRODUCTS LTD ( 532707 ) :- STELLAR RESULTS

Dear friends,


  We have discussed this stock @ 60 level on September 2014 stock now trading  @ 146 level .

    Today company posted results !!! . Q- Q  SALES 42.40 CR ( LAST YEAR 37.7 CR ) 13% JUMP , NET PROFIT 3.83 CR ( 2.44 CR ) 57% JUMP , Y -Y  SALES 144.9 CR ( 126 CR ) 15% JUMP NET PROFIT 13.44 CR ( 7.58 CR ) 78% JUMP , EPS 11.91 ( 6.69 ) 79 % JUMP !!!.  OVERALL STELLAR SET OF RESULTS !!! . COMPANY DECLARED 15% DIVIDEND.



Disclosure :- I am holding shares of  " Dynemic products " hence my views may be biased


                


OLD POST HERE

RESULTS HERE

Thursday, May 25, 2017

SUMEDHA FISCAL SERVICES LTD ( 530419 ) :- FOG 2 - ANSWER

Dear friends,



   I believe  this market correction is one more good buying opportunity for investor to their  favorite stocks in discount  price.  Find out gem ( FOG -2 ) answer is SUMEDHA FISCAL SERVICES LTD.  I received total 100 mail in that  30 readers given  correct answers .

 


    

   SUMEDHA FISCAL SERVICES LTD




                                                      Sumedha Fiscal Services



     Sumedha Fiscal Services Limited is a front ranking financial services Company incorporated in the year 1989.  The Company offers a wide bouquet of services ranging from Corporate Finance, Equities, Commodities, Insurance, Wealth Advisory, Portfolio Management, Personal Finance, Currency Futures, Investment Banking and Institutional Broking Services.

 


SERVICES :-

  


INVESTMENT BANKING 


  • Merchant Banking

  • Debt Syndication

  • Financial Restructuring

  • Portfolio Resolution of Stressed Assets

  • Mergers & Takeovers

  • Equity Placements



   WEALTH MANAGEMENT  





  • Financial Planning

  • Distribution Services

  • Insurance Advisory



  BROKING SERVICES 





  • Stock Broking

  • Commodity Broking

  • Depository Services

     


   Sumedha is a debt free company with clean balance sheet and good promoters quality . company posted awesome results in latest March 2017 quarter :-  6.35 cr top line ( last March 2.74 cr ) a jump of good 131 % Q-Q and EBITA  2.11 cr ( last March 0.30 cr ) a jump of 600 % and net profit of 1.38 cr ( last March 0.03 cr ) a jump of 4500 % . Now look into full year  results :- Top line 14.88 cr and bottom line 2.97 cr  a jump of 205 % !! . Company's total equity 7.98 cr company posted 3 cr net profit ( 37.5 % of paid up capital ) EPS comes 3.75 !!.  Sumedha is a regular dividend paying company ( 5% dividend ) but this year company announced 10 % dividend ( 1 rs ) if you calculate this to market price investor get 4.5 % dividend yield . Book value of the company stands 44.11 stock trading just above half of book value, this sector trading around 35 PE but this gem available just 6.4 PE !! Promoters holding good 49.57 % stake in company. On going bull run in equity market and economy  may push this stock give more encouraging results in coming quarters .  Stock trading only in BSE @ 25.70 level.

 

   CONCLUSION :- AFTER STELLAR QUARTER RESULTS STOCK ZOOMED 47 % IN 4 TRADING DAYS , SO MINIMUM RISK TAKER  NO NEED TO JUMP   INTO .BUT IF ANY  CORRECTION IS A   GOOD ENTRY OPPORTUNITY  FOR  MINIMUM RISK TAKERS .




RESULTS  HERE 



WEBSITE HERE





 

Before buying any stock take advice from certified person.




NOTE : THE ABOVE IS NOT A RESEARCH REPORT NOR A RECOMMENDATION  BUT INFORMATION AS AVAILABLE ON PUBLIC DOMAIN. 


Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”

Wednesday, May 24, 2017

............... :- UNDERVALUE STOCK

Dear friends,



  Find out this stock  this  is not a game, but it should   improve investors stock searching skill . Given 8 hints bellow , I think it may very esay to find this stock for normal investor. Name of the stock announcing on Friday morning






  1) STOCK TRADING ONLY IN BSE 


 2)  A DEBT FREE COMPANY


3 )  PROMOTER HOLDING MORE THEN 40 %


4 )  COMPANY POSTED  FULL YEAR PROFIT WAS  37.5% OF ITS PAID UP CAPITAL 


5)   REGULAR DIVIDEND PAYING COMPANY 


6 )  STOCK TRADING SINGLE PE 


7 ) STOCK TRADING BELOW ITS BOOK VALUE 

 

8 ) STOCK TRADING BELOW  99


Friday, May 19, 2017

AUTOLITE (INDIA) LIMITED :- E - RICKSHAWS PLAY

Dear friends,




 Today I am expressing my opinion in Auto segment stock for portfolio investors




                                      

              AUTOLITE (INDIA) LTD

                  




     Autolite (India) Limited is a holding company. The Company is engaged in the production of automotive headlamps and halogen bulbs. It offers products, including halogen bulbs, light-emitting diode (LED) lamps, head lamps, universal lamps, auxiliary lamps, earthmoving lamps and other lamps. Its auxiliary lamps include round driving lamps, mini lamps, mega lamps, mega driving lamps, round driving lamps and slim line driving lamps. Its LED lamps include LED ring lamps, LED indicator lamps and LED marker lamps. It also offers incandescent bulbs. The Company exports its products to approximately 50 countries. The Company supplies its products to original equipment manufacturers (OEMs) in automobile sectors and in replacement market in India through its dealer's distributor's network. It also manufactures machines, dies and molds. Its subsidiary is Autopal Inc., which is engaged in the trading of automotive headlamps and halogen lamps in the United States manufactured by the Company.

 


    NOW COMPANY ENTER TO  E- RICKSHAWS SPACE 

 



 Autolite enters e-rickshaw space; to grow lithium ion battery business



 Tapping the push given to electric vehicles  by the Indian Government, Jaipur-based lighting solutions company Autolite India  has diversified into the manufacture of e - rickshaws from early this month. Powered by lead acid batteries, the e-rickshaws are being marketed in three states of Rajasthan, Haryana and Uttar Pradesh through the company’s distribution network of 7 dealers.

 


 Company's director marketing and finance of Autolite  India told ET AUTO that the company has established a small production set up over 2 acres in its existing premises in Jaipur where currently 500 e-rickshaws are being rolled out per month. The plan is to set up a larger greenfield facility by end FY18 at another location in the city where about 2000 e-rickshaws can be manufactured monthly in view of their growing market demand.

 

 

  With the aim of being a long-term player in the EV space, Autolite under a joint venture company, Highstreet Lighting Limited, established a lithium ion battery plant in Gurgaon, Haryana last year. The JV is working closely with OE manufacturers to supply them lithium ion batteries on demand. Lithium ion batteries will power Autolite’s e-rickshaws, within a couple of months, to be followed by solar powered e-rickshaws as well.

 

 

   Promoter holding 53.95 % stake in company , Autolite posted 89 cr top line and 0.96 cr bottom line in latest 9 month ended 2016-17 ( last full year profit was 0.61 cr )  Indian Governments new electric vehicles push bring new era for this company . Autolite's promoters are very confident about new products , so patience investor can look into this stock for medium to long term portfolio.Stock trading both NSE and BSE @ 58.80  level. This one  stocks may give multiple return in coming month / years.

 

 

Before buying any stock take advice from certified person.




NOTE : THE ABOVE IS NOT A RESEARCH REPORT NOR A RECOMMENDATION  BUT INFORMATION AS AVAILABLE ON PUBLIC DOMAIN. 


Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”




ATISHAY LTD :- 95 % RETURN IN JUST 4 MONTH !!!

Dear friends,



   WE HAVE DISCUSSED   " ATISHAY LTD " @ 60 LEVEL ON JAN 2017  NOW STOCK TRADING @ 116.85 !!! SO 95% RETURN IN JUST 4 MONTHS 





               WHAT ELSE INVESTORS WANT ??




OLD POST HERE

Monday, May 15, 2017

STYLAM INDUSTRIES LTD :- 800% RETURN IN 30 MONTHS.

Dear friends,




  We have discussed  "STYLAM INDUSTRIES " @ 84 level on November 2014, today stock hit 755 level, so investors earned whooping 800% in just 30 months !!!



  WHAT ELSE INVESTORS WANT ??



  OLD POST HERE

Friday, May 12, 2017

ZOTA HEALTHCARE LTD :- LOOK INTO

Dear friends,



 Today I expressing my opinion on newly NSE SME listed pharma stock for value hunting investors.


                       ZOTA HEALTHCARE LTD 





                               
   
Image result for ZOTA HEALTH PRODUCTS PHOTO         Image result for ZOTA HEALTH PRODUCTS PHOTO



     Zota Health Care was originally incorporated on July 12, 2000 vide Certificate of Incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. It is a pharmaceutical company, engaged in developing, manufacturing and marketing pharmaceutical products. The company mainly market generic, patented and OTC pharmaceutical products, which it commercializes through the network of its distributor channel for its domestic sales.



The company started operations in 2000 by marketing pharmaceutical products on a local level. Over the years the company has built a steady position for itself in the domestic market. The backbone of the company’s revenue from operations is its distribution network, team of medical representatives and its marketing team. In addition to being vast, the company’s product portfolio is also diversified in nature, with its offerings ranging from allopathic medicine to ayurvedic to healthcare products. It offers varieties of tablets, capsules, ointments, oral liquids, injectable to meet customer needs. The company has also ensured to have its presence spread throughout the country and has achieved the same by supplying in all the 4 regions of the country. The company has applied for patent of 19 unique formulations, wherein it has been granted approvals for 6 formulations.



The company has also taken initiatives for digital marketing strategy and has already launched a mobile application for its division ‘Nutravedic.com’ and is in process of launching another application to integrate the markets and reach customers at large. Further, it has purchased the marketing rights of Astra-Idl for a period of three years to strengthen its market segment of generic medicines.

  

  Patented products:

 

 The company’s patented products are unique formulations providing edge over the generic products and influence financial success. As on the date, the company has 6 patented products and has applied for 13 more products for registration. Further, it has applied for PCT in 142 Countries for 9 formulations. With increased number of patented products the company will create more niche for its products thereby increasing the revenues of the company.



product range:

 

  The company has product portfolio across 21 divisions offering products under various therapeutic categories. This is coupled with the health care products. It manufactures products on the basis of needs and requirements in the market. The company markets around 3000 products in domestic market and has a portfolio of around 300 products for overseas market. The company has necessary resources, experience and network to launch additional products in future.

 

Global presence:

 

 Currently the company caters to markets in about five countries and is expecting approvals from other countries as well. It has marked export revenue of Rs 6.07 crore in the FY16 which is 9.34% of its total revenue. Also, the company’s manufacturing facility is set up in special economic zone, which abides by the CGMP guidelines structured WHO to meet international standards. This enables its manufacturing facility to register in various regulated and semi-regulated countries. The company’s footsteps in international market will help it to mitigate risk for any unforeseen circumstances in the domestic market. Currently the company caters to markets in about five countries and is expecting approvals from other countries as well. It has marked export revenue of Rs 6.07 crore in the FY16 which is 9.34% of its total revenue. Also, the company’s manufacturing facility is set up in special economic zone, which abides by the CGMP guidelines structured WHO to meet international standards. This enables its manufacturing facility to register in various regulated and semi-regulated countries. The company’s footsteps in international market will help it to mitigate risk for any unforeseen circumstances in the domestic market.



Future prospect

 

 Management indicated future out look in their 2016-17 annual reports :-  Forthcoming year company  enter into FMCG & OTC segment by launching energy drink product "DIP SIP" exclusively developed under brand Zota. Company also goingto launch online E COMMERCE APP and website NUTRAVEDIC.COM for selling of nutraceutical and ayurvedic products. ZOTA also apply for patent registration for company's patented product RTFIT in Asian, African and CIS countries.


FINANCIAL HIGHLIGHTS

 

Company posted good set of growth in top and bottom line :-  2011-12  sales 32 cr  and net profit 1.99 cr . 2012-13 sales 38.25 cr and net profit 2.54 cr . 2013-14 sales 45.60 cr and net profit 3.11 cr. 2014-15 sales 53.50 cr and net profit 4.26 cr . 2015-16 sales 58.66 cr and net profit 5.11 cr .For nine months of the current fiscal ended on 31.12.16 it has reported net profit of Rs. 3.94 crore on a turnover of Rs. 56.26 crore.  Zota health recently come out with IPO @ 125 .The issue was subscribed 15.9 times, with the company receiving bids worth 902 cr !! . After this huge ipo stock available near ipo price in secondary market , experience  and share holder friendly management company may attract value investors in coming days. Stock trading only in NSE SME segment @  127 level.   (1000 is the market lot )      



Before buying any stock take advice from certified person.




NOTE : THE ABOVE IS NOT A RESEARCH REPORT NOR A RECOMMENDATION  BUT INFORMATION AS AVAILABLE ON PUBLIC DOMAIN. 


Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”